Search

everythinglearnresearchcommunity

for

Search:↓

A substance called VIP might protect hair follicles from being attacked by the immune system, and problems with VIP signaling could lead to hair loss in alopecia areata.

Bimatoprost was found to be safer and more effective than mometasone furoate for treating scalp hair loss.

Intralesional steroids can help regrow hair in some alopecia areata patients but have side effects.

Certain HLA class II alleles increase or decrease the risk of alopecia areata.

Topical latanoprost doesn't effectively regrow hair in severe eyebrow alopecia areata cases.

Children with alopecia areata should only have thyroid screening if they have Down syndrome, a history of atopy, family history of thyroid disease, or signs of thyroid problems.

Dilated follicular infundibula and increased catagen/telogen follicles are key indicators for diagnosing alopecia areata.

Melanocytes might be targeted by the immune system in people with alopecia areata, but more research is needed.

Thioredoxin reductase 1 does not affect glucocorticoid receptor activity in hair follicle cells.

The research found specific signs to diagnose alopecia areata incognito and noted patients generally regrow hair after steroid treatment.

JAK inhibitors helped treat hair loss in two people with Down syndrome.

Alopecia affects patients' quality of life, with younger patients and longer-lasting hair loss experiencing greater impact.

Alopecia areata is linked to thyroid autoimmunity but not type 1 diabetes.

The study found no link between baldness patterns and androgen levels in men with benign prostate enlargement or prostate cancer.

JAK inhibitors are a promising new treatment for hair loss and nail problems in alopecia areata.

Older age at onset of alopecia areata leads to less severe and shorter episodes, with most patients experiencing significant hair regrowth.

People with alopecia areata often have lower vitamin D levels, which are linked to more severe and longer-lasting hair loss, but vitamin D receptor levels in the skin don't show the same pattern and don't predict treatment success.

Arachidonic acid helps hair grow by increasing growth factors and improving follicle health.

Methotrexate with corticosteroids can effectively treat severe alopecia areata but often requires long-term maintenance.

Baldness at age 40 is not linked to a higher risk of aggressive prostate cancer.

iNKT cells can help prevent and treat alopecia areata by promoting hair regrowth.

Oral tofacitinib may effectively treat hair loss in children with alopecia areata.

Dupilumab for atopic dermatitis may cause new or worsen existing alopecia areata.

Regenerative therapies show promise for treating vitiligo and alopecia areata.

New treatments for hair loss show promise, but more research is needed to confirm their safety and effectiveness.

Serum granulysin levels can indicate the activity and prognosis of alopecia areata.

Certain scalp patterns can indicate the severity and activity of hair loss in Turkish alopecia patients.

Botulinum toxin type A injections are not effective for severe alopecia areata.

Both androgenetic alopecia and alopecia areata negatively impact quality of life, with no significant difference between them.

Vitamin D levels do not affect the risk of developing alopecia areata.